Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

By G. Montalescot, P. Barragan, O. Wittenberg, P. Ecollan, S. Elhadad, Ph Villain, Jean-Marc Boulenc, M. Morice, L. Maillard, M. Pansieri and 2 more. New England Journal of Medicine, 2001

1,041 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology

View Paper: https://www.semanticscholar.org/paper/85619605da11b5c774ea69beda0c200afec596f9

Citations in the corpus

• 2018 ESC/EACTS Guidelines on myocardial revascularization. (2019, neutral): “IIa C Bivalirudin (0.75 mg/kg bolus, followed by 1.75 mg/kg/h for up to 4 h after the procedure) may be considered as an alternative to UFH.163,708,710,714,728 IIb A Crossover of UFH and LMWH is not recommended.705 III B b.i.d. = twice daily; GP = glycoprotein; i.v. = intravenous; LMWH = low-molecul”